US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Rhythm Pharmaceuticals Inc (RYTM)
Rhythm Pharmaceuticals Inc (RYTM) ニュース

RYTM

Rhythm Pharmaceuticals (RYTM)

Rhythm Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RYTM

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/02/05	22 : 00	GlobeNewswire Inc.	Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2025/02/05	11 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2025/02/05	11 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2025/01/10	21 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2025/01/10	21 : 15	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/12/21	04 : 15	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/12/03	20 : 00	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to incl	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/18	21 : 00	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/14	11 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/14	11 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/14	11 : 01	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/14	08 : 30	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/14	06 : 01	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces New Employment Inducement Grants	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/12	21 : 55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/09	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/08	06 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/07	07 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/06	22 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/06	22 : 00	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/06	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/06	06 : 01	GlobeNewswire Inc.	Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/11/05	06 : 01	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/10/24	19 : 00	GlobeNewswire Inc.	Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/10/23	21 : 00	GlobeNewswire Inc.	Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/10/09	05 : 01	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces New Employment Inducement Grants	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/09/20	05 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/09/17	05 : 01	GlobeNewswire Inc.	Rhythm Pharmaceuticals Announces New Employment Inducement Grants	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/09/12	05 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/08/29	05 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc
2024/08/27	05 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RYTM	Rhythm Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:RYTM

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

US Dollar vs Euro

Deutsche Telekom (QX)

Health Care Select Sector

Verizon Communications

US Dollar vs Sterling

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約